The ACI/ID Bioarchiving
facility has particularly
broad and unrivaled capabilities and expertise in the area of cell processing
and storage. Our many years of experience, wide range of clinical technologies,
and numerous highly qualified staff our facility the ideal
choice for the preservation and storage of clinical trial specimens. We welcome
the opportunity to collaborate with you.
v Enhancement of CD4+ T cell function by
blockade of the PD-1 pathway (2008-2014) 2500 vials of plasma and 2500 vials of
v University of Colorado Cancer Center
Hematologic Malignancies/Hematopoietic Stem Cell Transplant Tissue Protocol
(2011-Present). 3000 vials of plasma,
serum and buccal swabs, 2500 vials of PBMC.
v Lung HIV Microbiome Project (2009-2015). 200
vials bronchial lavage cells (BAL), 100 vials oral wash, 350 vials of stool,
1200 vials of plasma and 1200 vials of PBMC.
v Immunosuppressive Effects of Smoking and HIV-1
on the development of Lung Disease (2013-Present). 1260 vials of plasma, 1260 vials of PBMC, 210
vials of BAL, and 350 vials of stool HIV+/-.
v T-cell distribution and function in children
with cyanotic congenital heart disease (2014) 40 vials of plasma, 40 vials of
PBMC, 60 vials of thymocytes, 30
vials of snap-frozen thymus tissue.
v Factors mediating gut microbiota dysbiosis and
metabolic disease in HIV patients (2014-Present). 918 vials of plasma, 918 vials of PBMC, 250
vials of stool.
v Diet/Gut microbiome interaction and influence
of inflammatory disease in HIV patients (2015-Present) 588 vials of plasma, 588
vials of PBMC, 150 vials of stool, 270 vials of gut biopsy tissues.
v Analysis of prognostic cell signaling factors
in adolescent idiopathic scoliosis (2007-Present). 3000 vials of plasma and 3000 vials of PBMC.
v Types of samples banked: cord blood,
peripheral blood mononuclear cells (PBMC), bone marrow, plasma, serum, buccal
lavage cells (BAL), thymocytes,
intraepithelial gut lymphocytes, gut lamina propria lymphocytes (LPMC).